KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) EBITDA (2020 - 2025)

Historic EBITDA for Hims & Hers Health (HIMS) over the last 6 years, with Q3 2025 value amounting to $15.9 million.

  • Hims & Hers Health's EBITDA fell 7911.04% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.5 million, marking a year-over-year increase of 3233.71%. This contributed to the annual value of $125.8 million for FY2024, which is 63793.02% up from last year.
  • Per Hims & Hers Health's latest filing, its EBITDA stood at $15.9 million for Q3 2025, which was down 7911.04% from $43.5 million recorded in Q2 2025.
  • In the past 5 years, Hims & Hers Health's EBITDA registered a high of $76.0 million during Q3 2024, and its lowest value of -$51.5 million during Q1 2021.
  • Moreover, its 5-year median value for EBITDA was -$7.4 million (2023), whereas its average is $2.0 million.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 85308.25% in 2021, then soared by 193126.0% in 2024.
  • Over the past 5 years, Hims & Hers Health's EBITDA (Quarter) stood at -$31.2 million in 2021, then soared by 65.69% to -$10.7 million in 2022, then soared by 111.7% to $1.3 million in 2023, then soared by 1931.26% to $25.5 million in 2024, then crashed by 37.68% to $15.9 million in 2025.
  • Its EBITDA was $15.9 million in Q3 2025, compared to $43.5 million in Q2 2025 and $49.6 million in Q1 2025.